Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • India Must Reinvest in Its Civilisational Values to Achieve Prosperity: Industrialist H M Bangur at the World Hindu Economic Forum 2025 National
  • Meet Jyotsana Haldkar: who stunned everyone by posting contentful short videos on various social media platforms Lifestyle
  • SETJA’s Yarn and Jari Textile Expo- 2024 in Surat Attracts 100 Exhibitors Nationwide Business
  • Goel Ganga Group: Shaping Cities and Creating Exceptional Living Experiences Business
  • Rawls Salon Launches India’s First Ultra-Luxury ‘BEYOND’ Range with Jacqueline Fernandez Business
  • PetFood India: Nourishing Pets with Fresh and Natural Food Business
  • Jagadguru Kripalu Parishat Offers a Tribute- Our Ever-Glorious Badi Didi Lifestyle
  • Dr. Deepak Shenoy Honored with Global Visionary Entrepreneur Award, Medec Dragon Pvt Ltd Wins Best Managed Pharmaceutical Sustainable Organizations 2023  Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • My Health, My Right: Suggestions from Leading Health Experts on World Health Day 2024 Health
  • Better health of healthcare workers in India: A Closer Look Insights by Dr. Gopal Sharan MD & CEO of TRLS Healthcare Consultancy Health
  • Rasayanam Expands Its Wellness Range with Three New Powerhouse Products: Shilajit Gold, Magnesium Glycinate, and Shatavari Health
  • Gujarat’s first exclusive private Ayurveda multi-specialty Panchkarma Hospital inaugurated Health
  • Let Emotional Health Top | Embrace Parenthood Wholly With PREGSHIFT Health
  • Experts Call for Global Standardization of MGB/OAGB Surgery Health

Recent Posts

  • Sumeet Industries Announces Rs. 23.47 Cr Acquisition to Strengthen Polyester Chips Capacity
  • Identixweb Limited Announces SiteGrowth AI to Help SaaS Businesses Scale Organic Growth
  • Nura Sleep Wins “Best Orthopaedic Mattress of the Year” at the House of Lords
  • India’s Strategic Tightrope in Global Turmoil
  • KRAFTON India Signs MoU with DPIIT to Strengthen India’s Digital Entertainment and Interactive Media Ecosystem

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Mahamaya Steel Industries posted highest-ever December sales growth of 36.22% Business
  • Leading Digital Agency Techmagnate Releases 4th Edition of its Digital Report Card Business
  • Muzigal launches its State-of-the-art Music Academy in Shakti Nagar, New Delhi Education
  • Talentrack Academy for Digital Entertainment & Content (TADEC) announces the 6th edition of Talentrack Awards Business
  • Choosing right rehabilitation centre helps better outcomes: Dr. Vijay Bathina, Ucchvas Transitional Care Lifestyle
  • Gradding.com Launches New Gen AI-Powered IELTS Preparation Platform in India Technology
  • New Age production house IdeaRack enters OTT space with Runaway Lugaai for MX Player, stars Sanjay Mishra, Naveen Kasturia English
  • Lord’s Automative shines bright at EV INDIA EXPO 2023, Its cutting-edge EV Solutions receive overwhelming response Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme